ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
61 424,61
1,03%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sonoma Pharmaceuticals Inc (SNOAW)

  7. Sonoma Pharmaceuticals Inc (SNOAW) Actualités

SNOAW

Sonoma Pharmaceuticals (SNOAW)

Sonoma Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SNOAW
DateHeureSourceTitreSymboleSociété
27/02/202023h00GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe GroupNASDAQ:SNOAWSonoma Pharmaceuticals Inc
14/02/202023h30GlobeNewswire Inc.Sonoma Pharmaceuticals Reports Third Quarter FY 2020 Financial ResultsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
23/01/202022h43GlobeNewswire Inc.Sonoma Pharmaceuticals Engages Maxim Group LLC to Explore Strategic Opportunities for its U.S. Dermatology DivisionNASDAQ:SNOAWSonoma Pharmaceuticals Inc
29/11/201922h42GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Closing of $1.6 Million Public Offering of Common StockNASDAQ:SNOAWSonoma Pharmaceuticals Inc
26/11/201916h10GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Pricing of Approximately $1.6 million Public Offering of Common StockNASDAQ:SNOAWSonoma Pharmaceuticals Inc
26/11/201901h54GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:SNOAWSonoma Pharmaceuticals Inc
15/11/201900h00GlobeNewswire Inc.Sonoma Pharmaceuticals Reports Second Quarter FY 2020 Financial ResultsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
01/10/201923h09GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Management ChangesNASDAQ:SNOAWSonoma Pharmaceuticals Inc
13/08/201923h35GlobeNewswire Inc.Sonoma Pharmaceuticals Reports First Quarter FY 2020 Financial ResultsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
12/07/201915h00GlobeNewswire Inc.Sonoma Pharmaceuticals Regains Compliance with Nasdaq® Minimum Bid Price RuleNASDAQ:SNOAWSonoma Pharmaceuticals Inc
08/07/201922h03GlobeNewswire Inc.Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2019 Financial ResultsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
19/06/201922h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces 1-for-9 Reverse Split of Outstanding Common StockNASDAQ:SNOAWSonoma Pharmaceuticals Inc
21/05/201922h05GlobeNewswire Inc.Sonoma Pharmaceuticals Sells Animal Health Rights in Asia and Europe for $2.7 millionNASDAQ:SNOAWSonoma Pharmaceuticals Inc
12/03/201923h30GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Substantial Cost-Cutting MeasuresNASDAQ:SNOAWSonoma Pharmaceuticals Inc
17/11/201817h01GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Pricing of Public Offering of UnitsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
08/11/201822h03GlobeNewswire Inc.Sonoma Pharmaceuticals Reports Record Revenue in Second Quarter FY 2019NASDAQ:SNOAWSonoma Pharmaceuticals Inc
01/11/201812h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Second Quarter FY 2019 Financial Results and Conference CallNASDAQ:SNOAWSonoma Pharmaceuticals Inc
25/10/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Newly Published Results from Study of Hypochlorous Acid in Management of Hypertrophic and Ke...NASDAQ:SNOAWSonoma Pharmaceuticals Inc
17/10/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Launches New Ceramax™ Skin Barrier Lotion with Skin-Enriching Lipogrid Technology™NASDAQ:SNOAWSonoma Pharmaceuticals Inc
26/09/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Licensing of Antimicrobial Hypochlorous Acid Solution for Management of Blepharitis in the S...NASDAQ:SNOAWSonoma Pharmaceuticals Inc
19/09/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Appoints Phillipe Weigerstorfer to Board of DirectorsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
28/08/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Results from Study of Sonoma’s Performance-Stabilized HOCl™ (Hypochlorous Acid) in Manag...NASDAQ:SNOAWSonoma Pharmaceuticals Inc
08/08/201822h05GlobeNewswire Inc.Sonoma Pharmaceuticals Reports First Quarter FY 2019 Financial ResultsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
25/07/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces First Quarter FY 2019 Financial Results and Conference CallNASDAQ:SNOAWSonoma Pharmaceuticals Inc
13/06/201822h05GlobeNewswire Inc.Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2018 Financial ResultsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
05/06/201813h05GlobeNewswire Inc.U.SK, dermatology arm of Brazilian NC Group, and Sonoma Pharmaceuticals Enter into License Agreement for Exclusive Rights to ...NASDAQ:SNOAWSonoma Pharmaceuticals Inc
31/05/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces Fiscal Year/Fourth Quarter 2018 Financial Results and Conference CallNASDAQ:SNOAWSonoma Pharmaceuticals Inc
08/05/201813h00GlobeNewswire Inc.Sonoma Pharmaceuticals Names Marc Umscheid Chief Operating OfficerNASDAQ:SNOAWSonoma Pharmaceuticals Inc
17/04/201813h04GlobeNewswire Inc.Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal ProductsNASDAQ:SNOAWSonoma Pharmaceuticals Inc
05/04/201813h05GlobeNewswire Inc.Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy GelNASDAQ:SNOAWSonoma Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNOAW

Dernières Valeurs Consultées

EU
VK
Vallourec
EU
AI
Air Liquide
EU
PX1
CAC 40
EU
CAP
Capgemini
EU
AF
Air FranceKLM
EU
BNP
BNP Paribas
NASDAQ
AMZN
Amazon.com
EU
DG
Vinci
EU
ACA
Credit Agricole
NASDAQ
GOOGL
Alphabet
EU
ML
Michelin
COIN
ETHUSD
Ethereum
EU
ORA
Orange
COIN
BTCUSD
Bitcoin
EU
PX4
SBF 120
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés